[HTML][HTML] Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature

K Schwarze, J Buchanan, JC Taylor, S Wordsworth - Genetics in Medicine, 2018 - Elsevier
Purpose We conducted a systematic literature review to summarize the current health
economic evidence for whole-exome sequencing (WES) and whole-genome sequencing …

Genetics of mitochondrial diseases: Identifying mutations to help diagnosis

SL Stenton, H Prokisch - EBioMedicine, 2020 - thelancet.com
Mitochondrial diseases are amongst the most genetically and phenotypically diverse groups
of inherited diseases. The vast phenotypic overlap with other disease entities together with …

Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease

KJ Carss, G Arno, M Erwood, J Stephens… - The American Journal of …, 2017 - cell.com
Inherited retinal disease is a common cause of visual impairment and represents a highly
heterogeneous group of conditions. Here, we present findings from a cohort of 722 …

Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability

SH Lelieveld, MRF Reijnders, R Pfundt… - Nature …, 2016 - nature.com
To identify candidate genes for intellectual disability, we performed a meta-analysis on
2,637 de novo mutations, identified from the exomes of 2,104 patient–parent trios. Statistical …

A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders

Z Stark, TY Tan, B Chong, GR Brett, P Yap… - Genetics in …, 2016 - nature.com
Purpose: To prospectively evaluate the diagnostic and clinical utility of singleton whole-
exome sequencing (WES) as a first-tier test in infants with suspected monogenic disease …

MYH9: Structure, functions and role of non-muscle myosin IIA in human disease

A Pecci, X Ma, A Savoia, RS Adelstein - Gene, 2018 - Elsevier
The MYH9 gene encodes the heavy chain of non-muscle myosin IIA, a widely expressed
cytoplasmic myosin that participates in a variety of processes requiring the generation of …

Utility of whole‐exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care

SL Sawyer, T Hartley, DA Dyment… - Clinical …, 2016 - Wiley Online Library
An accurate diagnosis is an integral component of patient care for children with rare genetic
disease. Recent advances in sequencing, in particular whole‐exome sequencing (WES) …

Diagnostic impact and cost-effectiveness of whole-exome sequencing for ambulant children with suspected monogenic conditions

TY Tan, OJ Dillon, Z Stark, D Schofield, K Alam… - JAMA …, 2017 - jamanetwork.com
Importance Optimal use of whole-exome sequencing (WES) in the pediatric setting requires
an understanding of who should be considered for testing and when it should be performed …

A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology

LELM Vissers, KJ Van Nimwegen, JH Schieving… - Genetics in …, 2017 - nature.com
Purpose: Implementation of novel genetic diagnostic tests is generally driven by
technological advances because they promise shorter turnaround times and/or higher …

[HTML][HTML] Deep-intronic ABCA4 variants explain missing heritability in Stargardt disease and allow correction of splice defects by antisense oligonucleotides

R Sangermano, A Garanto, M Khan, EH Runhart… - Genetics in …, 2019 - Elsevier
Purpose Using exome sequencing, the underlying variants in many persons with autosomal
recessive diseases remain undetected. We explored autosomal recessive Stargardt disease …